| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2749 | 2020 |
| Acute infection and myocardial infarction DM Musher, MS Abers, VF Corrales-Medina New England Journal of Medicine 380 (2), 171-176, 2019 | 526 | 2019 |
| An immune-based biomarker signature is associated with mortality in COVID-19 patients MS Abers, OM Delmonte, EE Ricotta, J Fintzi, DL Fink, AAA de Jesus, ... JCI insight 6 (1), 2021 | 357 | 2021 |
| Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus DM Musher, MS Abers, JG Bartlett Clinical Infectious Diseases 65 (10), 1736-1744, 2017 | 224 | 2017 |
| Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19 C Liu, AJ Martins, WW Lau, N Rachmaninoff, J Chen, L Imberti, ... Cell 184 (7), 1836-1857. e22, 2021 | 207 | 2021 |
| Neurological and psychiatric adverse effects of antiretroviral drugs MS Abers, WX Shandera, JS Kass CNS drugs 28, 131-145, 2014 | 191 | 2014 |
| Neutrophil swarming delays the growth of clusters of pathogenic fungi A Hopke, A Scherer, S Kreuzburg, MS Abers, CS Zerbe, MC Dinauer, ... Nature communications 11 (1), 2031, 2020 | 113 | 2020 |
| Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 370: eabd4585 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... | 95 | 2020 |
| HGID Lab; NIAID-USUHS Immune Response to COVID Group; COVID Clinicians; COVID-STORM Clinicians; Imagine COVID Group; French COVID Cohort Study Group; Milieu Intérieur … P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 95 | 2020 |
| Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19 MS Abers, LB Rosen, OM Delmonte, E Shaw, P Bastard, L Imberti, ... Immunology and cell biology 99 (9), 917-921, 2021 | 91 | 2021 |
| HGID Lab P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... NIAID-USUHS Immune Response to COVID Group, 2020 | 67 | 2020 |
| Checkpoint inhibition and infectious diseases: a good thing? MS Abers, MS Lionakis, DP Kontoyiannis Trends in Molecular Medicine 25 (12), 1080-1093, 2019 | 44 | 2019 |
| C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection JV Desai, D Kumar, T Freiwald, D Chauss, MD Johnson, MS Abers, ... Cell 186 (13), 2802-2822. e22, 2023 | 43 | 2023 |
| Postobstructive pneumonia: an underdescribed syndrome MS Abers, BP Sandvall, R Sampath, C Zuno, N Uy, VL Yu, CE Stager, ... Clinical Infectious Diseases 62 (8), 957-961, 2016 | 42 | 2016 |
| A Critical Reappraisal of Prolonged Neutropenia as a Risk Factor for Invasive Pulmonary Aspergillosis. M Abers, M Ghebremichael, A Timmons, HS Warren, M Poznansky, ... Open Forum Infect Dis 3 (1), 2016 | 38 | 2016 |
| Abnormal movements in critical care patients with brain injury: a diagnostic approach Y Hannawi, MS Abers, RG Geocadin, MA Mirski Critical Care 20, 1-10, 2016 | 36 | 2016 |
| Low procalcitonin, community acquired pneumonia, and antibiotic therapy IS Kamat, V Ramachandran, H Eswaran, MS Abers, DM Musher The Lancet Infectious Diseases 18 (5), 496-497, 2018 | 31 | 2018 |
| Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics MS Abers, DM Musher QJM: An International Journal of Medicine 107 (7), 595-596, 2014 | 30 | 2014 |
| Serial procalcitonin as a predictor of bacteremia and need for intensive care unit care in adults with pneumonia, including those with highest severity: a prospective cohort study SM McCluskey, P Schuetz, MS Abers, B Bearnot, ME Morales, D Hoffman, ... Open forum infectious diseases 4 (1), ofw238, 2017 | 24 | 2017 |
| Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis RA Drummond, JV Desai, AP Hsu, V Oikonomou, DC Vinh, JA Acklin, ... The Journal of Clinical Investigation 132 (22), 2022 | 18 | 2022 |
Jatin M. Vyas, MD, PhDColumbia University Vagelos College of Physicians and SurgeonsVerified email at cumc.columbia.edu
